Speaker illustration

Doctor Guenther Staffler

Vienna (Austria)

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice

Date: 19 June 2017

Journal: European Heart Journal

Thumbnail

ESC 365 is supported by